Pulmonx Corp
LUNG
Market Cap$111.92M
Close$
Share Statistics
| Market cap | $111.92 Million |
|---|---|
| Enterprise Value | $74.77 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-1.44 |
| Beta | 0.52 |
| Outstanding Shares | 39,954,658 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.95 |
|---|---|
| PEG | -38.27 |
| Price to Sales | 1.39 |
| Price to Book Ratio | 2.78 |
| Enterprise Value to Revenue | 0.85 |
| Enterprise Value to EBIT | -1.16 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.5 |
| Debt to Equity | 0.48 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Pulmonx Corp
220 employeesPulmonx Corporation is a commercial-stage medical technology company. The Company is focused on providing planning tools and treatments for obstructive lung disease. Its solutions include Zephyr Valve, Chartis Pulmonary Assessment System...